Return to site

Review: Chinese Investment in Israeli Medical Tech

活动回顾|中国以色列医疗科技投资大会

October 20, 2021

 

在以色列,目前有成千上万家公司经营医疗保健和生命科学业务,毫无疑问,在医疗创新方面,以色列是一个全球强国。以色列在推进医疗技术的公司数量上仅次于美国,平均每年有100多家新公司成立。

In Israel, there are thousands of companies operate the healthcare and lifescience sectors today, and there isn’t a doubt that when it comes to medical innovation, Israel is a global powerhouse. Israel is placed second following the U.S. in the number of companies advancing medical technology, with an average of more than 100 new companies each year.

大会开幕/Openning Ceremony

在中国的“十四五”规划之下,促进创新和医疗技术可能是未来几年中国投资的重心。在此背景之下,10月14日,中国以色列商会ViaMeshi中以(上海)创新园国家技术转移东部中心共同组织了中国以色列医疗科技投资大会,旨在探讨中国在以色列医疗技术领域的投资机会。With China’s 5 year plan in mind, promotion of innovation and Medical technology would probably be the focus of Chinese investments in the next few years. With that in mind, at a unique event held on October 14th, IsCham, ViaMeshi, CIIH and “The National East Tech Transfer Center” organized an event focusing on Chinese Investments in the Israeli Medical Technology, in order to discuss the opportunities for Chinese investments in Israeli MedTech.

 

专题座谈会/Panel Discussion

来自以色列政府、中国医疗领域和中国公共部门的代表们出席了此次在中以(上海)创新园(CIIH)举办的活动。活动包含了专题座谈会,由BIE集团的总经理伊万·梅尔尼科夫(Ivan Melnikov)先生主持,参与座谈的嘉宾有:以色列驻上海总领事馆商务领事韩宁伟(Niv Hanan)先生、复星医药副总裁兼精准医疗产业部总经理汪曜先生、维昌洋行中国有限公司医疗板块总经理薛彧女士、SinoScience首席执行官塞格夫·哈芬(Segev Halfon)先生和来自以色列西博雷特律师事务所的赵佳欣女士。与会嘉宾探讨了未来以色列医疗技术在中国的发展态势和投资机会。

Representatives from the Israeli government, Chinese medical field, and the public sector in China came to the event that was held at the China Israel Innovation Hub (CIIH). The event comprised of a panel discussion hosted by BIE’s GM Mr. Ivan Melnikov, including the Economic Consul of Consulate General of Israel in Shanghai Mr. Niv Hanan; the Vice president and GM, Division of Precision Healthcare at Fuson Pharma Mr. William Wang; the GM of  Ekpac Medical Ms. Julie Xue; the CEO of Sinosciences LTD Mr. Segev Halfon; and the Associate lawyer at Shibolet & Co. Ms. Jiaxin Zhao. The panelists discussed opportunities for the future of Israeli med-tech in China.

在线路演/Online Roadshow 

 本次大会后半程包括一场路演活动,6家优秀的以色列公司参与其中,通过从以色列向上海现场连线的方式对中国投资者介绍了他们的创新医疗科技与服务。中国以色列商会参与路演活动的会员包括:SabarHealth, TytoCare, Sanolla, Hera-med, Ruilou Neurotech-solutionsVayyar。每家公司都介绍了自身能应用在医疗领域的技术,包含自我诊断、家庭怀孕监测等。每家公司展示结束还设置了快速的问答环节,从而进一步加深了解,激发两国之间的合作。

The second half of the event included a roadshow displaying 6 remarkable Israeli companies broadcasting live from Israel in order to introduce innovative MedTech to Chinese investors. IsCham’s members in the roadshow included Sabar Health, TytoCare, Sanolla, Hera-med, Ruilou Neurotech-solutions, and Vayyar. Each presented on a wide range of technologies that could be used in the medical field from self-diagnosis to at home pregnancy monitoring. Each presentation ended with a quick Q & A enabling further understanding, inspiring collaboration between the two nations.

If you are interested in talking to these Israeli companies, please feel free to contact us:

如果您对以上以色列企业感兴趣,欢迎联系:info@ischam.org